Recent advances in the diagnosis and treatment of attention-deficit/ hyperactivity disorder in individuals with intellectual disability

Mental Health Aspects of Developmental Disabilities

Volumn 10, Issue 4, 2007, Pages 121-128

  Huang, Haojiang ^a   Ruedrich, Stephen ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

ADHD; Behavioral phenotypes; Intellectual disability; Mental retardation; Psychiatric; Stimulants

Indexed keywords

CENTRAL STIMULANT AGENT; CLONIDINE; METHYLPHENIDATE; PLACEBO; RISPERIDONE;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC CRITERIA LEARNING DISABILITY; DIAGNOSTIC MANUAL INTELLECTUAL DISABILITY; DISEASE CLASSIFICATION; HUMAN; INTELLECTUAL IMPAIRMENT; MENTAL DEFICIENCY; PHENOTYPE; REVIEW; STANDARD; SYMPTOMATOLOGY;

EID: 39049096718     PISSN: 10573291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Abanilla PK, Hannahs GA, Wechsler R, Silva RR. The use of psychostimulants in pervasive developmental disorders. Psychiatr Q 2005;76:271-281.
2. Agarwal V, Sitholey P, Kumar S, Prasad M. Double-blind, placebo-controlled trial of Clonidine in hyperactive children with mental retardation. Ment Retard 2001;39:259-267.
3. Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. J Child Adolesc Psychopharmacol 2003;13:29-40.
4. Aman MG, Collier-Crespin A, Lindsay RL. Pharmacotherapy of disorders in mental retardation. Eur Child Adolesc Psychiatry 2000;9:198-107.
5. Aman MG, Kern RA, Osborne P, et al. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: Clinical effects. Am J Ment Retard 1997;101:521-534.
6. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. J Am Acad Child Adolesc Psychiatry 1999;38:5S-31S.
7. American Academy of Pediatrics. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-1170.
8. American Academy of Pediatrics. The Classification of Child and Adolescent Mental Diagnoses in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC) Child and Adolescent Version. Elk Grove Village, IL: Author, 1996.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). Washington, DC: American Psychiatric Association, 1980.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
13. Antshel KM, Fremont W, Roizen NJ, et al. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2006;45:596-603.
14. Antshel KM, Phillips MH, Gordon M, et al. Is ADHD a valid disorder in children with intellectual delays? Clin Psychol Rev 2006;26:555-572.
15. Arnsten AF. Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J Clin Psychiatry 2006;67:7-12.
16. Barry RJ, Leitner RP, Clarke AR, Einfeld SL. Behavioral aspects of Angelman syndrome: A case control study. Am J Med Genet A 2005;132:8-12.
17. Biederman J. Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 2005;57:1215-1220.
18. Burack JA, Evans DW, Klaiman C, Iarocci G. The mysterious myth of attentional deficits and other defect stories: Contemporary issues in the developmental approach to mental retardation. Int Rev Res Ment Retard 2001;24:300-321.
19. Campbell M, Fish B, David R, Shapiro T, et al. Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children. J Autism Child Schizophr 1972;2:343-358.
20. Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nat Rev Neurosci 2006;7:583-590.
21. Cooper SA, Melville CA, Einfeld SL. Psychiatric diagnosis, intellectual disabilities and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD). J Intellect Disabil Res 2003;47:3-15.
22. Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of mental retardation: Recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997;72:468-477.
23. Demb HB, Chang C. The use of psychostimulants in children with disruptive behavior disorders and developmental disabilities in a community setting. Ment Health Aspects Dev Disabil 2004;7:26-36.
24. Di Martino A, Melis G, Cianchetti C, Zuddas A. Methylphenidate for pervasive developmental disorders: Safety and efficacy of acute single dose test and ongoing therapy: An open-pilot study. J Child Adolesc Psychopharmacol 2004;14:207-218.
25. Douglas VI. Stop, look and listen: The problem of sustained attention and impulse control in hyperactive and normal children. Can J Behav Sci 1972;4:259-282.
26. Doyle AE. Executive functions in attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006;67:21-26.
27. Dykens EM, Hodapp RM. Research in mental retardation: Toward an etiologic approach. J Child Psychol Psychiatry 2001;42:49-71.
28. Epstein MH, Cullinan D, Polloway EA. Patterns of maladjustment among mentally retarded children and youth. Am J Ment Dene 1986;91:127-134.
29. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1313-1323.
30. Fox RA, Wade EJ. Attention deficit hyperactivity disorder among adults with severe and profound mental retardation. Res Dev Disabil 1998;19:275-280.
31. Gath A, Gumley D. Behaviour problems in retarded children with special reference to Down's syndrome. Br J Psychiatry 1986;149:156-161.
32. Gothelf D, Gruber R, Presburger G, et al. Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: An open-label study. J Clin Psychiatry 2003;64:1163-1169.
33. Gropman AL, Duncan WC, Smith AC. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatr Neurol 2006;34:337-350.
34. Handen BL, Janosky J, McAuliffe S. Long-term follow-up of children with mental retardation/ borderline intellectual functioning and ADHD. J Abnorm Child Psychol 1997;25:287-295.
35. Harris JC. Intellectual Disability: Understanding Its Development, Causes, Classification, Evaluation, and Treatment (Developmental Perspectives in Psychiatry). New York, NY: Oxford University Press, 2005.
36. Hastings RP, Beck A, Daley D, Hill C. Symptoms of ADHD and their correlates in children with intellectual disabilities. Res Dev Disabil 2005;26:456-468.
37. Ishii T, Takahashi O, Kawamura Y, Ohta T. Comorbidity in attention deficit-hyperactivity disorder. Psychiatry Clin Neurosci 2003;57:457-463.
38. Jones KL. Smith's Recognizable Patterns of Human Malformation, Fifth Edition. Philadelphia, PA: W.B. Saunders, 1997.
39. Jou R, Handen B, Hardan A. Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder. Australas Psychiatry 2004;12:376-379.
40. Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, et al. Prevalence of psychiatric disorders in 4 to 16- year-olds with Williams syndrome. Am J Med Genet B Neuropsychiatr Genet 2006;141:615-622.
41. Luckasson R, Bothwick-Duffy S, Buntinx WHE, et al. Mental Retardation Definition, Classification, and Systems of Supports, Tenth Edition. Washington, DC: American Association on Mental Retardation, 2002.
42. McCraken JT. Attention-deficit disorders. In: Sadock B, Sadock V (eds), Kaplan and Sadock's Comprehensive Textbook of Psychiatry, Eight Edition. Philadelphia, PA: Lippincott, Williams & Wilkins, 2000:2679-2687.
43. McGuffin P, Riley B, Plomin R. Genomics and behavior. Toward behavioral genomics. Science 2001;291:1232-1249.
44. Miller ML, Fee VE, Jones CJ. Psychometric properties of ADHD rating scales among children with mental retardation. Res Dev Disabil 2004;25:477-492.
45. Miller ML, Fee VE, Netterville AK. Psychometric properties of ADHD rating scales among children with mental retardation 1: Reliability. Res Dev Disabil 2004;25:459-476.
46. Morgan AE, Hynd GW, Riccio CA, Hall J. Validity of DSM-IV ADHD predominantly inattentive and combined types: Relationship to previous DSM diagnoses/subtype differences. J Am Acad Child Adolesc Psychiatry 1996;35:325-333.
47. Myers BA, Pueschel SM. Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis 1991;179:609-613.
48. National Association for the Dually Diagnosed (NADD). Diagnostic Manual - Intellectual Disability: Diagnosis of Mental Disorders in Persons with Intellectual Disability. Kingston, NY: NADD Press, 2007.
49. Pearson DA, Lane DM, Santos CW, et al. Effects of methylphenidate treatment in children with mental retardation and ADHD: Individual variation in medication response. J Am Acad Child Adolesc Psychiatry 2004;43:686-698.
50. Pearson DA, Santos CW, Casat CD, et al. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry 2004;43:677-685.
51. Posey DJ, Puntney Jl, Sasher TM, et al. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: A retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 2004;14:233-241.
52. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 2005;62:1266-1274.
53. Reyes M, Croonenberghs J, Augustyns I, Eerdekens M. Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: Efficacy, safety, and tolerability. J Child Adolesc Psychopharmacol 2006;16:260-272.
54. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 1970;126:983-987.
55. Royal College of Psychiatrists. Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD). London: Gaskell, 2001.
56. Seager MC, O'Brien G. Attention deficit hyperactivity disorder: Review of ADHD in learning disability: The Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD) criteria for diagnosis. J Intellect Disabil Res 2003;47:26-31.
57. Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry 2006;67:27-31.
58. Still GF. Some abnormal physical conditions in children: The Goulstonian Lectures. Lancet 1902;1:1008-1012.
59. Sullivan K, Hatton D, Hammer J, et al. ADHD symptoms in children with FXS. Am J Med Genet A 2006;140:2275-2288.
60. Wigren M, Hansen S. ADHD symptoms and insistence on sameness in Prader-Willi syndrome. J Intellect Disabil Res 2005;49:449-456.
61. World Health Organization. International Statistical Classification of Disease and Related Health Problems, Tenth Revision (ICD-10). Geneva, Switzerland, 1992.
62. World Health Organization. International Statistical Classification of Disease and Related Health Problems, Ninth Revision (ICD-9). Geneva, Switzerland: Author, 1977.
63. Zigler E. Developmental versus difference theories of mental retardation and the problem of motivation. Am J Ment Defic 1969;73:536-556.